EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieOpen Access · CC BY 4.0

Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor

Piotr Lukasz Rutkowski, Anna Klimczak, Pawel Teterycz, Maria Abbondanza Pantaleo, Tomasz Switaj, Pawel Rogala, Jan Poleszczuk, Margherita Nannini, Maria Concetta Nigro, Katarzyna Kozak

European Journal of Cancer · 2025-07 · 225 · 115565

DOI: 10.1016/j.ejca.2025.115565 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2025-07. Verfasst von Piotr Lukasz Rutkowski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electroni…. Hauptthemen laut MEDLINE: Axitinib, Gastrointestinal Stromal Tumors, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AxitinibGastrointestinal Stromal TumorsAntineoplastic Combined Chemotherapy ProtocolsGastrointestinal NeoplasmsHumansMiddle AgedMaleFemaleAgedAdultAged, 80 and overAntibodies, Monoclonal, HumanizedYoung AdultAdolescentProgression-Free Survival

Stichwörter der Autor:innen

AvelumabAxitinibGISTImmune checkpoint inhibitors

Substanzen

AxitinibavelumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: piotr.rutkowski@nio.gov.pl.
  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: anna.klimczak@nio.gov.pl.
  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland; Digital Medicine Centre Maria Sklodowska-Curie National Research Institute of O…
  • Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy. Electronic address: maria.pantaleo@unibo.it.
  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: tomasz.switaj@nio.gov.pl.
  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: pawel.rogala@nio.gov.pl.

Förderung

  • Pfizer

Zitieren

APA

Rutkowski, P. L., Klimczak, A., Teterycz, P., Pantaleo, M. A., Switaj, T., Rogala, P., Poleszczuk, J., Nannini, M., Nigro, M. C., & Kozak, K. (2025). Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer, 225, 115565. https://doi.org/10.1016/j.ejca.2025.115565

Vancouver

Rutkowski PL, Klimczak A, Teterycz P, Pantaleo MA, Switaj T, Rogala P, et al. Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer. 2025;225:115565. doi:10.1016/j.ejca.2025.115565

BibTeX
@article{Rutkowski2025,
  author = {Rutkowski, Piotr Lukasz and Klimczak, Anna and Teterycz, Pawel and Pantaleo, Maria Abbondanza and Switaj, Tomasz and Rogala, Pawel and Poleszczuk, Jan and Nannini, Margherita and Nigro, Maria Concetta and Kozak, Katarzyna},
  title = {Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {225},
  pages = {115565},
  doi = {10.1016/j.ejca.2025.115565}
}
Kostenlos starten →